ENTRY       D10101                      Drug
NAME        Crenezumab (USAN);
            Crenezumab (genetical recombination) (JAN)
FORMULA     C6348H9796N1688O2010S44
EXACT_MASS  143242.3924
MOL_WEIGHT  143330.6674
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYGMSWVRQA PGKGLELVAS INSNGGSTYY
            PDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCASGD YWGQGTTVTV SSASTKGPSV
            FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV
            VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPEFLGGP SVFLFPPKPK
            DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS TYRVVSVLTV
            LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM TKNQVSLTCL
            VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ EGNVFSCSVM
            HEALHNHYTQ KSLSLSLG
            (Light chain)
            DIVMTQSPLS LPVTPGEPAS ISCRSSQSLV YSNGDTYLHW YLQKPGQSPQ LLIYKVSNRF
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQSTHVP WTFGQGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H126-L219, H139-H195, H218-H'218, H221-H'221, H253-H313, H359-H417, H'22-H'96, H'126-L'219, H'139-H'195, H'253-H'313, H'359-H'417, L23-L93, L139-L199, L'23-L'199)
  TYPE      Peptide
EFFICACY    Dementia therapeutic agent
  TYPE      Monoclonal antibody
COMMENT     Treatment of Alzheimer's disease
TARGET      Amyloid beta [CPD:C16514 C16515]
DBLINKS     CAS: 1095207-05-8
            PubChem: 135626819
///
